(h) Printing equipment on, or connected to, manufacturing lines used to imprint labeling upon the drug product unit label or situation shall be monitored to assure that each one imprinting conforms into the print specified in the batch creation record.Products that tend not to comply with cGMP rules will not be necessarily viewed as unsafe, but as